{"id":960121,"date":"2026-05-07T18:05:23","date_gmt":"2026-05-07T22:05:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nu-skin-enterprises-reports-first-quarter-results\/"},"modified":"2026-05-07T18:05:23","modified_gmt":"2026-05-07T22:05:23","slug":"nu-skin-enterprises-reports-first-quarter-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nu-skin-enterprises-reports-first-quarter-results\/","title":{"rendered":"Nu Skin Enterprises Reports First Quarter Results"},"content":{"rendered":"

<\/p>\n

Nu Skin Enterprises Reports First Quarter Results<\/b><\/p>\n

PROVO, Utah–(BUSINESS WIRE<\/a>)–
\nNu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter revenue results within its guidance range.<\/p>\n

Executive Summary<\/b><\/p>\n

Q1 2026 vs. Prior-year Quarter<\/b><\/p>\n\n\n\n\n\n\n
\n

Revenue<\/b><\/p>\n<\/td>\n

\n

\n$320.6 million; (12.0)%<\/p>\n

\n\u00a0\u00a0\u2022 +1.1% FX impact or $3.9 million<\/p>\n<\/td>\n<\/tr>\n

\n

Earnings Per Share (EPS)<\/b><\/p>\n<\/td>\n

\n

\n$0.04 or $0.14 excluding certain charges compared to $2.14 or $0.23 excluding one-time gain from Mavely sale and other charges<\/p>\n<\/td>\n<\/tr>\n

\n

Customers<\/b><\/p>\n<\/td>\n

\n

\n669,535; (14)%<\/p>\n<\/td>\n<\/tr>\n

\n

Paid Affiliates<\/b><\/p>\n<\/td>\n

\n

\n120,850; (8)%<\/p>\n<\/td>\n<\/tr>\n

\n

Sales Leaders<\/b><\/p>\n<\/td>\n

\n

\n26,915; (13)%<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\n\u201cWe delivered first quarter revenue in line with our expectations and made further progress in our strategic priorities while operating in a volatile environment,\u201d said Ryan Napierski, Nu Skin president and CEO. \u201cAs we move through 2026, we are focused on empowering our sales leaders to scale our intelligent wellness platform with our latest innovation, Prysm iO\u2122, ahead of our full consumer rollout in the second half. We also continue to invest in laying the groundwork to expand our presence in emerging markets, including the formal launch of India anticipated in late 2026, while continuing to improve our operational discipline to return value to shareholders.<\/p>\n

\n\u201cWe are encouraged by early signs of improving paid affiliates and new sales leader development in several markets as our leaders begin integrating Prysm iO into their businesses and continue to build upon our leading anti-aging Tru Face\u00ae brand. We are focused on partnering with our sales force on leveraging the proprietary nutritional health biomarker tracking from Prysm iO to expand the channel as we prepare to drive customer subscriptions for our wellness products. While these initiatives will take time to develop, we remain confident that they will increase sales leader engagement and expand our global reach over time to drive the next phase of growth for Nu Skin.\u201d<\/p>\n

Q1 2026 Year-over-year Operating Results<\/b><\/p>\n\n\n\n\n\n\n\n\n\n\n\n
\n

Revenue<\/b><\/p>\n<\/td>\n

\n

\n$320.6 million compared to $364.5 million<\/p>\n

\n\u00a0\u00a0\u2022 +1.1% FX impact or $3.9 million<\/p>\n<\/td>\n<\/tr>\n

\n

Gross Margin<\/b><\/p>\n<\/td>\n

\n

\n66.9% or 67.9% excluding certain charges compared to 67.8%<\/p>\n

\n\u00a0\u00a0\u2022 Nu Skin business was 76.9% compared to 76.7%<\/p>\n<\/td>\n<\/tr>\n

\n

Selling Expenses<\/b><\/p>\n<\/td>\n

\n

\n34.3% compared to 32.5%<\/p>\n

\n\u00a0\u00a0\u2022 Nu Skin business was 40.5% compared to 38.7%<\/p>\n<\/td>\n<\/tr>\n

\n

G&A Expenses<\/b><\/p>\n<\/td>\n

\n

\n30.7% or 29.9% excluding certain charges compared to 31.1% or 28.9% excluding certain charges<\/p>\n<\/td>\n<\/tr>\n

\n

Impairment Expenses<\/b><\/p>\n<\/td>\n

\n

\n$1.8 million impairment compared to $25.1 million impairment<\/p>\n<\/td>\n<\/tr>\n

\n

Operating Margin<\/b><\/p>\n<\/td>\n

\n

\n1.3% or 3.6% excluding certain charges compared to (2.7)% or 6.4% excluding impairment and other charges<\/p>\n<\/td>\n<\/tr>\n

\n

Interest Expense<\/b><\/p>\n<\/td>\n

\n

\n$4.3 million compared to $3.3 million<\/p>\n<\/td>\n<\/tr>\n

\n

Other Income (Expense)<\/b><\/p>\n<\/td>\n

\n

\n$2.8 million compared to $(28.4) million<\/p>\n

\n\u00a0\u2022\u00a0Prior year reflects $28.1 million unrealized loss on investment<\/p>\n<\/td>\n<\/tr>\n

\n

Income Tax Rate<\/b><\/p>\n<\/td>\n

\n

\n29.4% compared to 20.1%<\/p>\n<\/td>\n<\/tr>\n

\n

EPS<\/b><\/p>\n<\/td>\n

\n

\n$0.04 or $0.14 excluding certain charges compared to $2.14 or $0.23 excluding one-time gain from Mavely sale and other charges\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

Stockholder Value<\/b><\/p>\n\n\n\n
\n

Dividend Payments<\/b><\/p>\n<\/td>\n

\n

\n$2.9 million<\/p>\n<\/td>\n<\/tr>\n

\n

Stock Repurchases<\/b><\/p>\n<\/td>\n

\n

\n$5.0 million<\/p>\n

\n\u00a0\u00a0\u2022 $137.3 million remaining in authorization<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

Q2 and Full-year 2026 Outlook<\/b><\/p>\n\n\n\n\n\n
\n

Q2 2026 Revenue<\/b><\/p>\n<\/td>\n

\n

\n$330 to $360 million; (15)% to (7)%<\/p>\n

\n\u00a0\u00a0\u2022 Approximately 0% FX impact<\/p>\n<\/td>\n<\/tr>\n

\n

Q2 2026 EPS<\/b><\/p>\n<\/td>\n

\n

\n$0.15 to $0.25<\/p>\n<\/td>\n<\/tr>\n

\n

2026 Revenue<\/b><\/p>\n<\/td>\n

\n

\n$1.35 to $1.50 billion; (9)% to 1%<\/p>\n

\n\u00a0\u00a0\u2022 Approximately (1)% FX impact<\/p>\n<\/td>\n<\/tr>\n

\n

2026 EPS<\/b><\/p>\n<\/td>\n

\n

\n$0.70 to $1.10 or $0.80 to $1.20 excluding certain charges<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\n\u201cIn addition to delivering on revenue and adjusted earnings, we returned $8 million to shareholders in the form of dividends and share repurchases,\u201d said Chelsea Lantz, interim chief financial officer. \u201cWe were also able to refinance our debt, extending our liquidity as we invest in growth initiatives and navigate market volatility while executing on our strategy. We are maintaining our annual guidance for 2026 on an adjusted basis. For the second quarter, we project revenue between $330 million and $360 million, with earnings per share in the range of $0.15 to $0.25.\u201d<\/p>\n

Conference Call<\/b><\/p>\n

\nThe Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company’s website at ir.nuskin.com<\/a>. A replay of the webcast will be available on the same page through May 21, 2026.<\/p>\n

About Nu Skin Enterprises Inc.<\/b><\/p>\n

Nu Skin Enterprises Inc.<\/a> (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company\u2019s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.<\/p>\n

Important Information Regarding Forward-Looking Statements: <\/i><\/b>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company\u2019s current expectations and beliefs. All statements other than statements of historical fact are \u201cforward-looking statements\u201d for purposes of federal and state securities laws and include, but are not limited to, statements of management\u2019s expectations regarding the company\u2019s performance, growth, initiatives, plans, areas of focus, sales force and customers, shareholder value, Prysm launch and its timing and potential benefits to the business, and emerging market expansion and its timing; projections regarding revenue, expenses, margins, tax rates, earnings per share, foreign currency fluctuations, uses of cash, financial position and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as \u201cbelieve,\u201d \u201cexpect,\u201d \u201cbecome,\u201d \u201ccontinue,\u201d \u201cproject,\u201d \u201coutlook,\u201d \u201cguidance,\u201d \u201cfocus,\u201d \u201cexpand,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cmay,\u201d \u201cmight,\u201d the negative of these words and other similar words.<\/i><\/p>\n

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:<\/i><\/p>\n